Sin conexión a internet: se muestra la versión guardada de la página.

Atara Biotherapeu…

USUSD
← Al screener

Atara Biotherapeutics Inc (LSE:0HIY) — Biotechnology: Biological Products (No Diagnostic Substances). Número de bolsas en las que cotizan las acciones de la empresa: 2. En esta página: cotización y gráfico, dividendos, principales accionistas e historial del número de acciones.

Sobre la empresa

Sitio web
atarabio.com
Relaciones con los inversores
investors.atarabio.com/news-events/press-releases
Sector
Health Care · Biotechnology: Biological Products (No Diagnostic Substances)
Sede central
South San Francisco, United States
Consejero delegado
Anhco Nguyen
Empleados
10
Fundada
2012
Cotiza desde
29.01.2018 (LSE:0HIY)
Acciones en circulación
10.04 M a 2026-08-10
Capital flotante
4.62 M
Capitalización bursátil
95.16 M USD
Insiders
16.8%
Inversores institucionales
57.67%
Industria (SIC)
Biological Products, (No Diagnostic Substances)
LEI
549300WBXUXZRE03MS38
FCF
−50.9 M USD
Deuda
0
Resultados y FCF — para los 12 meses hasta 30.06.2026 (el último informe de la empresa).
Descripción

Atara Biotherapeutics, Inc. engages in the development of transformative therapies for patients with cancer and autoimmune disease in the United States and internationally. Its lead product includes Tab-cel (tabelecleucel), a T-cell immunotherapy program that is in Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) with post-transplant lymphoproliferative disease, as well as other EBV-driven diseases. It also develops ATA3219, an allogeneic CAR T targeting CD19 intended to target B-cell malignancies and autoimmune diseases. The company has research collaboration agreements with Memorial Sloan Kettering Cancer Center, and Council of the Queensland Institute of Medical Research. Atara Biotherapeutics, Inc. was incorporated in 2012 and is headquartered in Thousand Oaks, California.

Bolsas y tickers

BolsaTickerMonedaPrecioTipo
US USA StocksATRA principalUSD9.23 -1.49%acciones ordinarias
LSE London Stock Exchange0HIY IOBUSD9.01 +0.00%acciones ordinarias

Precio en 3 meses

día alcista día bajistaPasa el cursor / toca un día — precios de apertura, cierre, máximo y mínimo

Noticias de esta semana

No hay noticias en la última semana. Últimas noticias: 30.09.2026.

anuncio

Principales accionistas

TitularParticipaciónAccionesFecha del informe
EcoR1 Capital, LLC15.46%1.55 M2026-06-30
CIONGOLI GREGORY AUSTIN…≈12.17%1.22 M2026-06-09
Adage Capital Partners G…8.47%850 0002026-06-30
Point72 Asset Management…6.85%687 7182026-06-30
Redmile Group, LLC4.4%441 7012026-06-30
Vanguard Capital Managem…2.46%247 0472026-06-30
Mackenzie Financial Corp…2.32%233 2492026-06-30
CHERRY BRIAN N (Director…≈1.66%166 4862026-09-04
VANGUARD INDEX FUNDS-Van…1.58%158 6462026-06-30
NGUYEN ANHCO T (Chief Ex…≈1.32%132 7752026-08-17
Blackrock Inc.0.84%84 4552026-06-30
VANGUARD INDEX FUNDS-Van…0.82%82 7582026-06-30
TOUCHON PASCAL (Director…≈0.78%77 9552025-06-10
Geode Capital Management…0.75%75 1282026-06-30
HYLLENGREN ERIC J (Chief…≈0.56%56 2312025-03-03
Staley Capital Advisers,…0.5%50 0002026-06-30
Vanguard Fiduciary Trust…0.43%43 0362026-06-30
Fidelity Concord Street…0.35%35 3922026-07-31
iShares Trust-iShares Mi…0.19%18 8242026-08-31
Varbl Insurance Prod. Fd…0.16%16 2382026-07-31
Fidelity Concord Street…0.11%11 1752026-07-31
Fidelity Concord Street…0.1%10 4792026-07-31
Fidelity Concord Street…0.05%4 6122026-07-31
VANGUARD Inst. INDEX Fd.…0.03%2 8442026-06-30
VANGUARD VALLEY FORGE FU…0.03%2 7992026-06-30
ADIUMENTUM CAPITAL FUND…——2025-05-16
ECOR1 CAPITAL, L.L.C. (B…——2026-05-07
PANACEA INNOVATION LTD (…——2026-05-07
PANACEA VENTURE (Benefic…——2025-11-28
REDMILE GROUP, L.L.C. (U…——2026-07-22